Tag: FDA approvals
Paragon BioTeck, Inc. receives FDA Approval for Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.
